Immutep (IMMP) Operating Income (2012 - 2024)
Immutep's (IMMP) quarterly Operating Income came in at -$17.3 million in Q4 2024, down 14.74% YoY from -$20.3 million in Q1 2024, and up 43.7% on a QoQ basis from -$30.7 million in Q2 2024.
Immutep (IMMP) Operating Income (2012 - 2024) Analysis & Trends
Immutep (IMMP) has 9 years of Operating Income data on file, last reported at -$17.3 million in Q4 2024.
- Quarterly Operating Income fell 14.74% year-over-year to -$17.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$77.1 million (down 67.05% YoY) and the FY2024 annual result came in at -$30.7 million, changed N/A from the prior year.
- Operating Income climbed to -$17.3 million in Q4 2024, from -$30.7 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$12.3 million in Q4 2021 to a low of -$30.7 million in Q2 2024.
- A 4-year average of -$17.9 million and a median of -$15.1 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income declined 6.9% — and 2024, when it dropped 14.74%.
- Tracing IMMP's Operating Income over 4 years: stood at -$12.3 million in 2021, then declined by 14.73% to -$14.1 million in 2022, then slipped by 6.9% to -$15.1 million in 2023, then dropped by 14.74% to -$17.3 million in 2024.
- The last three Operating Income figures came in at -$17.3 million (Q4 2024), -$30.7 million (Q2 2024), and -$15.1 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 133.12 Mn |
| 10 | Immutep | 56.27 Mn | -8.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -17.28 Mn |
| Jun 30, 2024 | -30.68 Mn |
| Dec 31, 2023 | -15.06 Mn |
| Dec 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | -12.28 Mn |
| Dec 31, 2019 | -4.74 Mn |
| Jun 30, 2019 | -14.15 Mn |
| Dec 31, 2018 | -7.17 Mn |
| Dec 31, 2016 | -3.51 Mn |
| Jun 30, 2015 | -4,973.17 |
| Dec 31, 2012 | -8.27 Mn |